Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine Relapse Prevention Study in Schizophrenia
NCT01412060Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Sep 2011
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Forest Laboratories. Started Sep 2011; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01412060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412060.